Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation and Cognitive Behavioral Therapy for Insomnia in MCI

NCT06687161 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT06687161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06687161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation and Cognitive Behavioral Therapy for Insomnia in MCI
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2025
Completion date
June 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, mild cognitive impairment (mci)